Instron, a leading provider of testing equipment solutions designed to evaluate mechanical properties of materials and components, is pleased to announce the acquisition of Tissue Growth Technologies (TGT), a premier supplier of commercial bioreactors to grow and stimulate developing tissues.

TGT will become part of the Instron division of ITWs Test and Measurement business. In partnership, we are excited to offer an instrumentation platform that is uniquely designed to cater to all aspects of tissue engineering. Our broad range of applications includes:

? condition and engineer developing tissues

? characterize tissue engineering components

? reveal fundamental mechanisms of cell function

? direct stem cell differentiation

? provide an in vitro testbed for drug and cell therapy development

“Instron and TGT are excited about this new partnership. Not only is Instron gaining the knowledge and experience of TGT, but we’re now able to provide a full range of solutions for the tissue engineering and regenerative medicine fields,” said James Ritchey, Instron’s Director of Tissue Engineering Businesses.

For more information on Instron’s products and services, visit www.instron.com. Click on ‘Contact Us’

to locate a sales, service and technical support office near you.

For more information on TGT’s products, visit www.tissuegrowth.com.